146 related articles for article (PubMed ID: 17369780)
61. ATF1 and RAS in exosomes are potential clinical diagnostic markers for cervical cancer.
Shi Y; Wang W; Yang B; Tian H
Cell Biochem Funct; 2017 Oct; 35(7):477-483. PubMed ID: 29023897
[TBL] [Abstract][Full Text] [Related]
62. [Post therapeutic cervical cancer surveillance in France: Priority for examination].
Bourgin C; Estevez JP; Collinet P
Gynecol Obstet Fertil Senol; 2018 May; 46(5):503-505. PubMed ID: 29615374
[No Abstract] [Full Text] [Related]
63. Novel approaches to early detection of endometrial cancer.
Bagaria M; Shields E; Bakkum-Gamez JN
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):40-46. PubMed ID: 27861202
[TBL] [Abstract][Full Text] [Related]
64. [Biological markers of cancer. Critical study].
Bellet D; Bidart JM
Presse Med; 1993 Apr; 22(14):680-6. PubMed ID: 8511115
[TBL] [Abstract][Full Text] [Related]
65. The impact of diagnosis on cervical and endometrial cancer patients and their spouses.
Lalos A
Eur J Gynaecol Oncol; 1997; 18(6):513-9. PubMed ID: 9443025
[TBL] [Abstract][Full Text] [Related]
66. Reply to: 'Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies'.
Bruno M; Bizzarri N; Scambia G; Ferrandina G
Eur J Surg Oncol; 2024 Jun; 50(6):108238. PubMed ID: 38494362
[No Abstract] [Full Text] [Related]
67. In silico analysis of protein neoplastic biomarkers for cervix and uterine cancer.
Rodríguez-Pérez MA; Medina-Aunon A; Encarnación-Guevara SM; Bernal-Silvia S; Barrera-Saldaña H; Albar-Ramírez JP
Clin Transl Oncol; 2008 Oct; 10(10):604-17. PubMed ID: 18940741
[TBL] [Abstract][Full Text] [Related]
68. Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies.
Farooqi HA; Nabi R
Eur J Surg Oncol; 2024 Jun; 50(6):108239. PubMed ID: 38458881
[No Abstract] [Full Text] [Related]
69. Detection of endometrial cancer by flow cytometry using two monoclonal antibodies.
Kobiki K; Tsukasaki K; Kubushiro K; Kobayashi Y; Hasegawa K; Fukuchi T; Banno K; Nozawa S
Cytometry; 1999 Jun; 36(2):150-6. PubMed ID: 10554163
[TBL] [Abstract][Full Text] [Related]
70. Potential application of body fluids autofluorescence in the non-invasive diagnosis of endometrial cancer.
Švecová M; Fiedlerová K; Mareková M; Dubayová K
Klin Onkol; 2024; 38(2):102-109. PubMed ID: 38697818
[TBL] [Abstract][Full Text] [Related]
71. New markers for monitoring occupational cancer: the example of oncogene proteins.
Brandt-Rauf PW
J Occup Med; 1988 May; 30(5):399-404. PubMed ID: 3286845
[TBL] [Abstract][Full Text] [Related]
72. New metabolic-endocrine risk markers in endometrial cancer.
Stoll BA
Br J Obstet Gynaecol; 1999 May; 106(5):402-6. PubMed ID: 10430187
[No Abstract] [Full Text] [Related]
73. Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium.
Selim MA
Gynecol Oncol; 1997 Jul; 66(1):164-5. PubMed ID: 9234940
[No Abstract] [Full Text] [Related]
74. Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques.
Tavakoli F; Khatami SS; Momeni F; Azadbakht J; Ghasemi F
Comb Chem High Throughput Screen; 2021; 24(5):605-623. PubMed ID: 32875976
[TBL] [Abstract][Full Text] [Related]
75. [What importance do tumor markers have in life insurance medicine?].
Binsack T; Kraus HK
Versicherungsmedizin; 1990 Dec; 42(6):157-62. PubMed ID: 2291265
[TBL] [Abstract][Full Text] [Related]
76. [The role of cytokines as tumor markers].
Mroczko B; Szmitkowski M
Pol Arch Med Wewn; 1997 Feb; 97(2):170-6. PubMed ID: 9312766
[No Abstract] [Full Text] [Related]
77. Biomarkers for risk assessment in molecular epidemiology of cancer.
Verma M
Technol Cancer Res Treat; 2004 Oct; 3(5):505-14. PubMed ID: 15453816
[TBL] [Abstract][Full Text] [Related]
78. Biochemical and immunologic diagnosis of cancer. Functional histopathology.
Cordon-Cardo C; Oettgen HF; Melamed MR
Tumour Biol; 1987; 8(2-3):177-8. PubMed ID: 3448764
[No Abstract] [Full Text] [Related]
79. Immunohistochemical markers in uterine tumour diagnostics.
Danihel L; Babál P; Porubský J; Zaviacic M; Breitenecker G; Janek L
Bratisl Lek Listy; 1995 Jul; 96(7):353-60. PubMed ID: 7552414
[TBL] [Abstract][Full Text] [Related]
80. Early detection of endometrial cancer.
Ge J; Fader AN; Dudley JC
Gynecol Oncol; 2023 Jul; 174():A1-A2. PubMed ID: 37356825
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
